SAN ANTONIO, November 05, 2025--bioAffinity Technologies announced the volume of CyPath® Lung tests processed in October ...

Leesburg, VA, November 2, 2022—According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR), metrics derived from dual-energy CT (DECT) can provide insight on ...

BARCELONA, Spain — For patients with emphysema who are suitable candidates for lung volume reduction surgery, there were no differences at 1 year in either lung function, dyspnea, or exercise capacity ...

bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW),a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today announced sales of its CyPath® Lung ...

We’ve all felt winded when taking the stairs or dealt with a cough from time to time. But if these issues linger, they could be early signs of chronic obstructive pulmonary disease (COPD). If you have ...

There are limited data from randomized trials regarding whether volume-based, low-dose computed tomographic (CT) screening can reduce lung-cancer mortality among male former and current smokers. A ...